Weineng S. Feng
Foshan Key Laboratory Of Precision Therapy In Oncology And Neurology
Foshan, China
Foshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.
Journal: JAMA
Published: August 10, 2026
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.
Journal: JAMA
Published: June 17, 2026
Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.
Journal: JAMA oncology
Published: January 29, 2026
Genetically Predicted Gut Microbiota and Lymphoma Risk: A Mendelian Randomization Study.
Journal: Current pharmaceutical biotechnology
Published: January 25, 2026
RORγ drives non-small cell lung cancer progression by upregulating the NGF signaling.
Journal: Respiratory research
Published: October 28, 2025
Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs . immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.
Journal: Chinese medical journal
Published: September 29, 2025
GPNMB Drives Brain Metastasis by Sculpting a Pathologic Endothelial-Immune Interactome.
Journal: Cancer discovery
Published: September 23, 2025
Artificial intelligence-based pathological model for pan-cancer lymph node metastasis detection: a multicentre diagnostic study with retrospective and prospective validation.
Journal: The Lancet. Digital health
Published: July 01, 2025
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 20, 2025
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib.
Journal: Signal transduction and targeted therapy
Published: March 20, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.
Journal: Signal transduction and targeted therapy
Published: November 25, 2024
Transcriptomic analysis of transformed small-cell lung cancer from EGFR-mutated lung adenocarcinoma reveals distinct subgroups and precision therapy opportunities.
Journal: Biomarker research
Published: November 06, 2024
Last Updated: 09/26/2026